A pan-cancer study by Federico et al. showed that transcriptional deregulation of INTS13 is significantly prevalent, occurring in 8 of 22 analyzed cancer types, with significant upregulation observed in rectum AC, small cell lung cancer, and cholangiocarcinoma [31]. This evidence concerns the gene INTS13 and cholangiocarcinoma.